4 Insights on decentralized trials for biotechs
The COVID-19 pandemic accelerated the adoption of decentralized clinical trials (DCTs) by biopharma companies. The clinician-patient relationship will always be key to clinical trials, but decentralized aspects such as direct-to-patient shipments and telehealth are here to stay. Here are four things we have learned about DCTs that biotech companies can consider when designing a decentralized or hybrid trial.
Related Insights
Playbook
Insights from the 2022 R&D Innovation Survey
Feb 17, 2023
Blog
Scientific Advances: Catalyst for Biotech Investment and Innovation in Clinical Development
Mar 12, 2024
Blog
Master Protocol Trials: What Are the Elements of Success?
Dec 1, 2021
Blog
Decentralized Trials: Considerations for Building a New Patient-Centric Model
May 13, 2021
Podcast
Enabling Successful Sites, Ep3: Taking the complexity out of oncology clinical trials
Jun 28, 2024
Podcast
Enabling Successful Sites, Ep2: Empowering Sites to be More Inclusive Through Cultural Sensitivity Training
Jun 28, 2024
Article
How a joined-up development strategy pays off for early-stage biotechs
May 19, 2021
Article
How emerging biotechs can enter the Chinese market and prosper
Jan 18, 2022
Case Study
Case Study Lifecycle maintenance
Nov 25, 2021
Case Study
Case Study Marketing Authorization Transfer
Nov 25, 2021
Article
Three strategies for articulating a coherent product value story
Dec 18, 2021
Video
Biotech Showcase: Fireside Chat with Jamie Macdonald
Jan 3, 2022
Related Insights
Playbook
Insights from the 2022 R&D Innovation Survey
Feb 17, 2023
Blog
Scientific Advances: Catalyst for Biotech Investment and Innovation in Clinical Development
Mar 12, 2024
Blog
Master Protocol Trials: What Are the Elements of Success?
Dec 1, 2021
Blog
Decentralized Trials: Considerations for Building a New Patient-Centric Model
May 13, 2021
Podcast
Enabling Successful Sites, Ep3: Taking the complexity out of oncology clinical trials
Jun 28, 2024
Podcast
Enabling Successful Sites, Ep2: Empowering Sites to be More Inclusive Through Cultural Sensitivity Training
Jun 28, 2024
Article
How a joined-up development strategy pays off for early-stage biotechs
May 19, 2021
Article
How emerging biotechs can enter the Chinese market and prosper
Jan 18, 2022
Case Study
Case Study Lifecycle maintenance
Nov 25, 2021
Case Study
Case Study Marketing Authorization Transfer
Nov 25, 2021
Article
Three strategies for articulating a coherent product value story
Dec 18, 2021
Video
Biotech Showcase: Fireside Chat with Jamie Macdonald
Jan 3, 2022